Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Molecular Models02:00

Molecular Models

38.9K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
38.9K
Synthetic Biology02:55

Synthetic Biology

4.9K
Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
4.9K
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.2K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

835
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
835

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating AI and Causal Genetics to Prioritize Therapeutic Targets for Aging and Age-Related Diseases.

Aging and disease·2026
Same author

Novel drug targets in 2025.

Nature reviews. Drug discovery·2026
Same author

From Prompt to Drug: Toward Pharmaceutical Superintelligence.

ACS central science·2026
Same author

Target identification and assessment in the era of AI.

Nature reviews. Drug discovery·2026
Same author

Advancing target discovery through disease-specific integration of multi-modal target identification models and comprehensive benchmarking system.

Scientific reports·2026
Same author

An Internal Sulfur-Lone Pair Interaction Enabled the Discovery of Potent and Sub-Family Selective PKMYT1 Inhibitors.

ChemMedChem·2026

Related Experiment Video

Updated: Aug 12, 2025

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.1K

Chemistry42: An AI-Driven Platform for Molecular Design and Optimization.

Yan A Ivanenkov1, Daniil Polykovskiy2, Dmitry Bezrukov1

  • 1Insilico Medicine Kong Kong Ltd., Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Pak Shek Kok, Hong Kong.

Journal of Chemical Information and Modeling
|February 2, 2023
PubMed
Summary

Chemistry42, an AI-powered drug discovery platform, efficiently designs novel small molecules for targets like DDR1 and CDK20. This software accelerates the identification of optimized drug candidates, validated through preclinical studies.

More Related Videos

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
08:21

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids

Published on: April 13, 2022

2.7K
Automated Robotic Liquid Handling Assembly of Modular DNA Devices
11:22

Automated Robotic Liquid Handling Assembly of Modular DNA Devices

Published on: December 1, 2017

12.5K

Related Experiment Videos

Last Updated: Aug 12, 2025

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.1K
Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids
08:21

Curation of Computational Chemical Libraries Demonstrated with Alpha-Amino Acids

Published on: April 13, 2022

2.7K
Automated Robotic Liquid Handling Assembly of Modular DNA Devices
11:22

Automated Robotic Liquid Handling Assembly of Modular DNA Devices

Published on: December 1, 2017

12.5K

Area of Science:

  • Computational chemistry
  • Medicinal chemistry
  • Artificial intelligence in drug discovery

Background:

  • Drug discovery relies on identifying and optimizing novel molecular structures.
  • Computational and medicinal chemistry approaches are essential for efficient small molecule design.
  • Artificial intelligence (AI) offers powerful tools for accelerating drug discovery processes.

Purpose of the Study:

  • To demonstrate the efficacy of the Chemistry42 platform for *de novo* small molecule design.
  • To showcase the platform's capability in generating novel molecular structures optimized for specific biological targets.
  • To illustrate the application of Chemistry42 in identifying potential drug candidates against DDR1 and CDK20.

Main Methods:

  • Utilizing the Chemistry42 software platform, which integrates AI with computational and medicinal chemistry.
  • Employing *de novo* molecular design and optimization algorithms.
  • Validating generated molecular structures through *in vitro* and *in vivo* studies (as per abstract).

Main Results:

  • Chemistry42 efficiently generated novel molecular structures with optimized properties.
  • The platform successfully identified potential small molecules targeting DDR1 and CDK20.
  • The generated molecules were validated in *in vitro* and *in vivo* studies, demonstrating efficacy.

Conclusions:

  • Chemistry42 is a powerful AI-driven platform for *de novo* small molecule design and optimization.
  • The platform enables efficient identification of novel drug candidates against specific targets like DDR1 and CDK20.
  • Chemistry42 is a core component of Insilico Medicine's Pharma.ai drug discovery suite, enhancing overall drug development capabilities.